PHYT SEC filings, in plain English
Everything Pyrophyte Acquisition Corp. has filed with the SEC that we hold — 40 filings, newest first, 39 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: A Form 12b-25 Notification of Late Filing submitted by Pyrophyte Acquisition Corp. with respect to its Quarterly Report on Form 10-Q for the period ended June 30, 2026. The filing discloses that the Company cannot meet the regulatory deadline for the June 30, 2026 quarterly report. Why it matters: Outstanding periodic filings during a SEARCHING phase typically restrict market activities, complicate initial business combination timelines, and increase suspension or de-listing exposure without formally altering the redemption calendar. Registrant-attributed forward-looking statements warn that an ongoing review may identify errors or control deficiencies in the Company’s accounting practices, and there is no assurance the Form 10-Q will clear within the permitted five-day extension.
What changed: Schedule 13G/A amendment filing appended with Exhibit A, a Joint Filing Agreement. In its own terms, this document is a routine compliance exhibit. Signed on August 14, 2026, by Frederick V. Fortmiller, Jr. acting as Managing Member for Harraden Circle Investments, LLC, the text solely executes a mutual consent to file the parent Schedule 13G and any subsequent amendments jointly under Rule 13d-1(k). Bearing on SPAC mechanics, the filing introduces no alterations to redemption windows, trust distribution procedures, extension voting calendars, or target acquisition milestones, and documents no deviations in sponsor conduct. Reporting whatever else of substance, the exhibit contains no statements, projections, or commitments regarding customer demographics, revenue figures, market sizing, corporate strategy, intellectual property, commercial partnerships, active litigation, or executive team movements. The only datum recorded in the text is the execution date of August 14, 2026. Why it matters: While administratively conventional, the agreement confirms that Harraden Circle Investments, LLC maintains its passive equity position through the stipulated reporting conduit without approaching ownership thresholds that would trigger Schedule 13D classification or activist signaling. For investors tracking redemption deadlines, trust accretion, extension feasibility, or deal momentum, this submission operates as a regulatory baseline: it neither advances the merger clock, modifies the cash reserve trajectory, nor provides actionable intelligence on management's pursuit of a business combination, thereby leaving the declared SEARCHING status and shareholder rights intact pending future substantive disclosures.
What changed: A Joint Filing Statement pursuant to Rule 13d-1(k) attached to a Schedule 13G/A beneficial ownership report. The document contains no provisions altering redemption calendars, trust account distributions, extension proposals, business combination milestones, or sponsor conduct. It functions solely as an administrative acknowledgment that multiple affiliated entities will submit subsequent amendments together, without triggering any SPAC mechanical events. Why it matters: Beyond the mechanics, the exhibit identifies the reporting group as First Trust Merger Arbitrage Fund, First Trust Capital Management L.P., First Trust Capital Solutions L.P., and FTCS Sub GP LLC. Signed by Joy Ausili (Trustee, Vice President and Assistant Secretary) and Chad Eisenberg (Chief Operating Officer), the filing states that each undersigned entity acknowledges individual responsibility for the timeliness and accuracy of its own contained information, while expressly disclaiming responsibility for the others’ data unless known to be inaccurate. Dated August 14, 2026, and tracked under [0001604488-26-000097], this routine compliance exhibit clarifies cross-entity disclosure liabilities for future 13G/A filings but offers no substantive claims regarding customer relationships, revenue, market size, strategy, technology, partnerships, litigation, or executive personnel changes.
What changed: A routine compliance exhibit—a Limited Power of Attorney attached to a Schedule 13G/A—granting designated Mizuho officers the authority to execute and file Form 13G amendments with the SEC. This document does not modify redemption deadlines, trust value, extension provisions, target acquisition progress, or sponsor conduct. Under Sections 13(d) and 13(g) of the Exchange Act, it solely confirms internal delegation so that Takahiro Katsura (Managing Director, Head of Global Branches & Subsidiaries Coordination Office) may file on behalf of Mizuho Financial Group, Inc., while Shuji Matsuura (Senior Managing Corporate Executive, Head of Global Corporate & Investment Banking; Managing Executive Officer, Head of Global Corporate & Investment Banking Division) and Adam Hopkins (Chief Legal Officer; Managing Director, General Counsel) authorize filing on behalf of Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC. The text contains no assertions regarding PHYT’s business operations, capital structure, or transaction timeline. Why it matters: It indicates that Mizuho-affiliated entities are maintaining standard regulatory disclosure procedures, reflecting routine institutional administration rather than a tactical shift in position or involvement in a de-SPAC combination. All organizational details—including the subsidiary classifications in Exhibit A, the principal office addresses listed by Mizuho Bank, Ltd. (1-5-5, Otemachi, Chiyoda-ku, Tokyo 100-8176, Japan) and its U.S. affiliates (1271 Avenue of the Americas, NY, NY 10020, USA), and the execution date of 8-13-2026—are attributable exclusively to Mizuho Financial Group, Inc. and its authorized representatives. The filing contains no commercial projections, partnership announcements, litigation references, or treasury directives that would affect shareholder redemption calculus or trust distribution expectations.
What changed: A Form 8-K current report classified as a routine compliance exhibit disclosing 'Other Events' under Item 8.01. The filing reports that Pyrophyte Acquisition LLC (the Sponsor) deposited $100,000 into the trust account on June 8, 2026, and another $100,000 on July 20, 2026. These deposits fulfill the monthly extension obligation established at the April 28, 2026 extraordinary general meeting, which extended the deadline to consummate an initial business combination from April 29, 2026 to April 29, 2027. Chief Financial Officer Sten Gustafson attested to these events on August 4, 2026. Why it matters: Mechanically, the dual deposits confirm the sponsor's adherence to the $100,000 monthly funding schedule, directly increasing the trust balance to support the per-share redemption price while halting the liquidation countdown until April 29, 2027. The filing signals continued sponsor commitment without triggering early redemption or warranting amendment notices. No additional substance exists regarding customer claims, revenue metrics, market size, strategic initiatives, technology roadmaps, commercial partnerships, active litigation, or senior leadership changes beyond the routine CFO signature block.
What changed: Quarterly report (Form 10-Q) for the period ended September 30, 2025. The trust account dropped from ~$73.8M (Dec 31, 2024) to ~$18.7M (Sep 30, 2025) after the Third Extension Meeting on April 25, 2025, where holders of 4,776,757 public shares redeemed at ~$11.95/share for ~$57.1M. As of Sep 30, 2025, only 1,513,954 redeemable shares remained at $12.36 per share. Net loss for nine months was ~$14.4M driven by a $14.0M non-cash charge from the change in fair value of warrant liabilities and an $868,338 charge for the conversion option on the promissory notes. The outside date for the Sio Business Combination was extended to April 29, 2027 (fifth amendment, March 13, 2026), and a Fourth Extension Meeting on April 28, 2026 extended the liquidation deadline to April 29, 2027. At that meeting, 100,100 public shares redeemed at ~$12.93/share, leaving ~$18.3M in trust. Post-quarter end, the company drew $609,364 under the extension loan and $755,899 under the working capital loan. Sponsor has advanced $3,305,769 in total extension loans as of Sep 30, 2025. Why it matters: The trust is shrinking rapidly and the SPAC now has only 1.5M shares outstanding — a very small base — and an extended deadline to April 2027. The massive fair value swing on warrants and the new conversion option liability signal significant accounting volatility. The going concern footnote is explicit: management has "substantial doubt" about the company's ability to continue as a going concern. The fourth amendment to the Sio deal (Oct 2025) and fifth amendment (Mar 2026) show the target deal continues but hasn't closed; investors need to watch for further extensions or a deal failure.
What changed vs 2026-05-22trust $18.3M → $18.7M +2%shares 6.29M → 1.51M -76%trust account, redeemable shares, combination deadline +32 moved · 4 with no prior record of ours
- Trust account
- $18.3M$18.7M
- Redeemable shares
- 6.29M1.51M
- Combination deadline
- 2027-04-29 · unchanged
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $1.6M · unchanged
- Mandate language
- we may pursue an initial business combination opportunity in… · unchanged
SpacBrain reads this as $374,545 was added to the trust between the two filings.
The clause …“due from Sponsor 151,395 360,000 Total current assets 239,397 493,597 Cash held in Trust Account 18,654,790 73,782,674 Total Assets $ 18,894,187 $ 74,276,271 LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND”…
SpacBrain reads this as 4,776,757 shares are no longer redeemable.
The clause “0 issued and outstanding at September 30, 2025 and December 31, 2024 (excluding 1,513,954 and 6,290,711 ordinary shares subject to possible redemption, respectively) 503 503 Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares”…
The clause …“of the Company’s liquidation. If the Company does not consummate an initial business combination by April 29, 2027, the Fourth Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited,”…
The clause …“As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with ASC Subtopic 205-40, “ Presentation of Financial Statements – Going Concern ,” management has determined that”…
The clause “As of September 30, 2025 and December 31, 2024, the Company had $ 2,078,077 and $ 1,641,875 outstanding under the Working Capital Loans respectively. Extension Loans In connection with the First Extension, the Sponsor agreed to loan the”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Quarterly report on Form 10-Q for the period ended June 30, 2025, filed by Pyrophyte Acquisition Corp. (PHYT), a blank-check company searching for a business combination. Trust value dropped from $73.8M (Dec 2024) to $18.3M (Jun 2025) due to 4.78M share redemptions at ~$11.95 in the Third Extension (Apr 2025). Trust per share increased from $11.77 to $12.11. The liquidation deadline was extended from Apr 29, 2026 to Apr 29, 2027 via the Fourth Extension (Apr 28, 2026), with 100,100 additional redemptions at ~$12.93 leaving ~$18.3M in trust. The Sio business combination outside date was further extended to Apr 29, 2027 (fifth amendment Mar 13, 2026). Sponsor agreed to increase monthly extension deposits to $100,000 through Apr 2027. The company reported a net loss of $8.2M for 6 months (vs $2.0M net income in prior year), driven by $8.7M non-cash loss from warrant revaluation. The company disclosed a material weakness in internal controls and a going concern qualification. Why it matters: This filing provides updated trust value, per-share redemption price, and extension timeline critical for redemption decisions. It shows the sponsor continues to fund extensions, but the trust is shrinking and the deal with Sio remains unconsummated with multiple deadline extensions. The company's financial losses and control weaknesses raise risk. The trust per share has risen slightly, but the extended deadline to Apr 2027 gives more time for a deal.
What changed vs 2026-05-22trust $74.6M → $18.3M -76%trust account, combination deadline, going-concern doubt +31 moved · 5 with no prior record of ours
- Trust account
- $74.6M$18.3M
- Combination deadline
- 2027-04-29 · unchanged
- Going-concern doubt
- stated · unchanged
- Sponsor loans outstanding
- $1.6M · unchanged
- Mandate language
- we may pursue an initial business combination opportunity in… · unchanged
- Redeemable shares
- 6.29M · unchanged
SpacBrain reads this as $56,357,094 left the trust between the two filings.
The clause …“due from Sponsor 151,395 360,000 Total current assets 283,374 493,597 Cash held in Trust Account 18,280,245 73,782,674 Total Assets $ 18,563,619 $ 74,276,271 LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND”…
The clause …“of the Company’s liquidation. If the Company does not consummate an initial business combination by April 29, 2027, the Fourth Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited,”…
The clause …“As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with ASC Subtopic 205-40, “ Presentation of Financial Statements – Going Concern ,” management has determined that”…
The clause …“As of June 30, 2025 and December 31, 2024, the Company had $ 2,059,076 and $ 1,641,875 outstanding under the Working Capital Loans respectively. Extension Loans In connection with the First Extension, the Sponsor agreed to loan the”…
The clause …“outstanding at June 30, 2025 and December 31, 2024 respectively (excluding 6,290,711 shares subject to possible redemption) 503 503 Additional paid-in capital - - Accumulated deficit ( 27,135,235 ) ( 17,324,017 ) Total shareholders'”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Quarterly report (Form 10-Q) for Pyrophyte Acquisition Corp. for the three months ended March 31, 2025, including unaudited financial statements. As of March 31, 2025, the trust held $74,897,339 for 6,290,711 public shares, implying a redemption value of $11.91 per share (up from $11.77 at December 31, 2024). Net loss for the quarter was $3.19 million vs. net income of $1.94 million in prior year quarter, driven by a $3.64 million negative change in fair value of warrant liabilities. The sponsor advanced an additional $270,000 in extension contributions during the quarter. Subsequent to quarter end: (1) on April 25, 2025, 4,776,757 shares redeemed at ~$11.95, leaving ~$18.1 million in trust; (2) on April 28, 2026, a fourth extension to April 29, 2027 was approved with 100,100 additional shares redeemed at ~$12.93. The Sio Business Combination outside date was extended multiple times, now to April 29, 2027. Management expressed substantial doubt about the company's ability to continue as a going concern due to limited cash and the mandatory liquidation deadline. Why it matters: This filing confirms the trust's current per-share redemption value, the sponsor's continued funding of extensions, the ongoing erosion of trust assets through successive redemptions, and the company's reliance on multiple deadline extensions to consummate the Sio deal. The going concern warning and delisting to OTC Pink highlight elevated risk of liquidation if the business combination does not close before April 29, 2027.
What changed vs 2024-11-14trust $98.9M → $74.6M -25%deadline 2025-04-29 → 2027-04-29sponsor loan $723K → $1.6Mtrust account, combination deadline, sponsor loans outstanding +33 moved · 3 with no prior record of ours
- Trust account
- $98.9M$74.6M
- Combination deadline
- 2025-04-292027-04-29
- Sponsor loans outstanding
- $723K$1.6M
- Going-concern doubt
- stated · unchanged
- Mandate language
- we may pursue an initial business combination opportunity in… · unchanged
- Redeemable shares
- 6.29M · unchanged
SpacBrain reads this as $24,232,770 left the trust between the two filings.
The clause …“due from Sponsor 360,000 360,000 Total current assets 553,298 493,597 Cash held in Trust Account 74,637,339 73,782,674 Total Assets $ 75,190,637 $ 74,276,271 LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND”…
SpacBrain reads this as 730 days later than the previous record.
The clause …“of the Company’s liquidation. If the Company does not consummate an initial business combination by April 29, 2027, the Fourth Extension Note will be repaid only from funds held outside of the Trust Account or will be forfeited,”…
SpacBrain reads this as the sponsor has advanced $918,553 more.
The clause …“As of March 31, 2025 and December 31, 2024, the Company had $ 2,042,875 and $ 1,641,875 outstanding under the Working Capital Loans respectively. Extension Loans In connection with the First Extension, the Sponsor agreed to loan the”…
The clause …“As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with ASC Subtopic 205-40, “ Presentation of Financial Statements – Going Concern ,” management has determined that”…
The clause …“outstanding at March 31, 2025 and December 31, 2024 respectively (excluding 6,290,711 shares subject to possible redemption) 503 503 Additional paid-in capital - - Accumulated deficit ( 21,368,885 ) ( 17,324,017 ) Total shareholders’”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: SEC Form 12b-25 (Notification of Late Filing) submitting a request for an extension to file Pyrophyte Acquisition Corp.’s Quarterly Report on Form 10-Q for the period ended March 31, 2026. Why it matters: A pattern of missed SEC reporting cycles undermines investor oversight during the mandatory search phase, complicating independent validation of sponsor draw limits, operating expenses, and trust account integrity. The acknowledged potential for undisclosed accounting control weaknesses raises governance red flags that can pressure the board on timing for merger proposals, extension approvals, or liquidation triggers.
What changed: A Form 8-K current report (Item 8.01 Other Events) filed by Pyrophyte Acquisition Corp. documenting the results of an extraordinary general meeting, including a SPAC initial business combination extension, shareholder redemptions, revised trust account balances, and sponsor-funded maintenance deposits. According to the registrant’s Item 8.01 disclosure, shareholders approved at an extraordinary general meeting on April 28, 2026 an extension of the time to consummate an initial business combination from April 29, 2026 to April 29, 2027. Per the Company’s statement, holders of 100,100 Class A ordinary shares exercised redemption rights, resulting in approximately $1.29 million being removed from the Trust Account at approximately $12.93 per share. Following these redemptions, approximately $18.3 million remained in the Trust Account as of April 30, 2026. The registrant further states that post-redemption capitalization consists of 6,445,104 Class A Ordinary Shares outstanding, made up of 1,413,854 shares originally issued in the IPO and 5,031,250 shares originally issued to Pyrophyte Acquisition LLC as Class B ordinary shares. The filing also discloses that the Sponsor committed to depositing $100,000 monthly into the Trust Account through the Extension, and on May 4, 2026, the Sponsor caused the first month’s $100,000 deposit to be made. Beyond these structural changes, the document contains no claims about customers, revenue, market size, strategy, technology, partnerships, or litigation. It identifies the registrant as a Cayman Islands blank check company (SIC 6770) headquartered in Houston, Texas, with administrative execution attributed to Chief Financial Officer Sten Gustafson. Why it matters: This filing directly recalibrates the trust distribution floor and public share count ahead of the newly established April 29, 2027 deadline. Investors tracking redemption windows will note the $12.93 per-share payout and the $18.3 million residual trust balance, which defines the maximum recoverable amount if dissolution occurs before a deal closes. The reduction of 100,100 shares lowers the outstanding public float to 6,445,104 shares, altering relative voting weight and future dilution exposure. The contractual requirement for $100,000 monthly sponsor contributions extends the trust’s liquidity runway and financially commits the sponsor to preserving liquidation value throughout the extension, indicating active continuation of deal pursuit despite the complete absence of any target announcement, revenue projection, or operational milestone. All metrics, dates, and commitments are sourced exclusively from the registrant’s Item 8.01 report.
What changed: A Joint Filing Agreement (Exhibit A) accompanying a Schedule 13G beneficial ownership report. The document records only the procedural authorization by which eight affiliated parties—Harraden Circle Investments, LLC; Harraden Circle Investors GP, LP; Harraden Circle Investors GP, LLC; Harraden Circle Investors, LP; Harraden Circle Special Opportunities, LP; Harraden Circle Strategic Investments, LP; Harraden Circle Concentrated, LP; and Frederick V. Fortmiller, Jr.—consent to file a single Schedule 13G on behalf of each under Rule 13d-1(k). Dated April 30, 2026, and executed solely by Frederick V. Fortmiller, Jr. as Managing Member or authorized signatory, the excerpt provides zero data on aggregate share quantity, percentage of outstanding common stock, acquisition price, date of acquisition, or stated purpose of the purchase. Accordingly, no adjustment to redemption deadline calculations, trust-per-share distributions, extension balloting windows, combination vote scheduling, or sponsor governance conduct is triggered or disclosed by this text. Why it matters: Investors tracking SPAC mechanics receive no operational update from this page because the core Schedule 13G information sheet—which would normally specify whether the Harraden Circle complex crossed a reporting threshold, intends to acquire additional shares, or seeks board representation—is entirely absent. The bundling of multiple limited partnerships and their general partner into one joint filing reflects routine compliance administration rather than a tactical accumulation or activism move. With no claims regarding customer contracts, recurring revenue, addressable market size, strategic pivot, proprietary technology, partnership arrangements, active litigation, or executive appointments contained in the exhibit, the filing carries no direct weight on capital structure searches, target negotiation timelines, or shareholder liquidity events. Materiality remains low until the accompanying data schedule or purpose statement becomes publicly available.
What changed: A Form 8-K current report documenting a shareholder-approved trust account extension, the issuance of sponsor-directed promissory notes, and a temporary extension of the public share redemption reversal deadline. Per the filing by Pyrophyte Acquisition Corp., shareholders voted 6,366,583 For, 0 Against, and 0 Abstain to amend the Articles to extend the initial business combination deadline from April 29, 2026 to April 29, 2027. Concurrently, the Company increased mandatory monthly trust account loans from the Sponsor from the greater of $0.05 per public share or $75,000 to a flat $100,000 per calendar month beginning April 30, 2026. The filing grants existing redemption request holders a revised reversal window closing Friday, May 1, 2026 at 5:00 p.m. Eastern Time through transfer agent Continental Stock Transfer & Trust Company. Financial obligations were also updated: the Company issued a Fourth Extension Note to Sponsor Pyrophyte Acquisition LLC with a maximum principal of $1,200,000 bearing zero percent interest, repayable solely from non-trust funds upon liquidation or consummation. Additionally, the Working Capital Convertible Promissory Note was amended to extend its maturity to the Extended Date, raise its aggregate limit to $2,500,000, and grant the Sponsor an option to convert up to $1,500,000 into warrants at a $1.00 conversion price, with each warrant entitled to purchase one Class A ordinary share at $11.50 per share. Amendments to Article 51.7 and 51.8 clarify a ten-business-day post-deadline liquidation window and preserve 100 percent redemption triggers for future charter modifications. Why it matters: This filing confirms the Sponsor’s commitment to sustain operations for an additional twelve-month extension cycle using fully subordinated, trust-waived debt, indicating active pursuit of a target rather than imminent liquidation. The $100,000 monthly contribution rate directly offsets trust account erosion from ongoing corporate and administrative expenses, meaning the actual per-share trust value available at redemption will reflect cumulative monthly deductions over the additional year. The compressed May 1 reversal deadline establishes a discrete liquidity event for public investors before the new funding cycle commences. From a capital structure standpoint, the convertible note provision introduces conditional dilution: if the Sponsor elects to convert up to $1,500,000 prior to a business combination, it would inject warrants exercisable at $11.50 per share that carry identical rights to the original private placement warrants but escape their standard forfeiture clauses. The document contains no disclosures regarding target candidates, pipeline meetings, revenue projections, market sizing, operational strategy, or strategic rationale beyond routine governance amendments and financial accommodation terms.
What changed: A DEFA14A filing containing an 8-K current report (Item 8.01 Other Events) submitted by Pyrophyte Acquisition Corp. on April 22, 2026, serving as definitive additional materials disclosing trust account updates, extension payment confirmations, and proxy logistics ahead of a fourth shareholder meeting to extend the business combination deadline. The Company reports that as of April 22, 2026, the Trust Account holds approximately $19,545,779. The Company states there are currently 1,513,954 Class A ordinary shares eligible for redemption at the upcoming Fourth Extension EGM, and calculates that the implied liquidation value for those shares, if redeemed at that meeting, is approximately $12.91 per Public Share. The Company attributes to the Sponsor, Pyrophyte Acquisition LLC, a prior agreement to deposit $75,697.70 monthly through the Third Extension period (which was approved on April 25, 2025, extending the combination deadline to April 29, 2026), and states the Company has confirmed all such Extension Amounts were deposited. The Company further notes that an Extension Proxy Statement dated April 8, 2026 was mailed to shareholders of record as of March 27, 2026, approximately on April 9, 2026, to solicit votes for a fourth extension. Why it matters: This filing materially shifts the near-term redemption calendar by activating preparations for a Fourth Extension EGM and supplying the precise trust balance (~$19,545,779) and per-share liquidation metric (~$12.91) investors must weigh against the 1,513,954 outstanding public shares when deciding whether to redeem. By documenting that the sponsor funded the previous monthly extension installments at $75,697.70 per month, the filing confirms sponsor conduct and illustrates the cash infusions sustaining the trust pool ahead of the next deadline. No target acquisition, revenue figures, technology disclosures, or partnership announcements are contained in the text; instead, the document relies on standard forward-looking risk disclaimers and designates Chief Financial Officer Sten Gustafson as the contact for obtaining the definitive proxy statement. For investors tracking SPAC mechanics, the substance lies in the verified extension payment trail and the recalculated liquidation floor, which together dictate whether existing positions should be hedged, tendered, or maintained pending the outcome of the fourth extension vote.
What changed: An Item 8.01 'Other Events' Form 8-K current report issued by Pyrophyte Acquisition Corp. to notify the market that the sponsor has completed all required extension deposits, to disclose the updated trust account balance, to calculate the projected per-share liquidation value ahead of a shareholder redemption vote, and to direct investors to the definitive proxy statement governing a proposed fourth extension. According to the Company’s filing, signed by Chief Financial Officer Sten Gustafson on April 22, 2026, Pyrophyte Acquisition LLC has successfully deposited every monthly extension amount of $75,697.70 previously pledged for the Third Extension period, which extended the business combination deadline from April 29, 2025, to April 29, 2026. As of April 22, 2026, the Company states the Trust Account holds approximately $19,545,779. The filing identifies 1,513,954 Class A ordinary shares as currently eligible for redemption at the Fourth Extension EGM, and projects an implied liquidation value of approximately $12.91 per Public Share if redeemed at that meeting. The Company further advises that its definitive proxy statement dated April 8, 2026 was mailed to shareholders of record as of March 27, 2026, around April 9, 2026. Outside of these capital, extension, and proxy mechanics, the filing contains only standard forward-looking statement disclaimers, risk factor cross-references to the 2024 Form 10-K and the Extension Proxy Statement, participant solicitation disclosures, and a non-solicitation legal notice; it reports no target acquisition details, customer data, revenue projections, technology roadmaps, partnership agreements, pending litigation, or executive personnel changes. Why it matters: The document materially updates the redemption calendar by pinpointing the Fourth Extension EGM as the near-term catalyst where public shareholders can exercise redemption rights against the trust fund. By confirming the sponsor fully satisfied its $75,697.70 monthly payment schedule, the filing serves as a compliance checkpoint regarding sponsor capital contributions during the extension phase. For investors monitoring trust value and capital preservation, the reported $19,545,779 balance and the Company’s stated $12.91 per-share approximation establish the theoretical redemption floor tied to the upcoming vote, though the Company explicitly frames this figure as contingent on proper submission for redemption at the Fourth Extension EGM and subject to proxy approval. The mailing of the definitive proxy statement initiates the formal voting window, requiring holders to review the extension proposal, associated risks, and participant interests before the April 29, 2026, contractual deadline expires.
What changed: A Form 8-K current report under Item 8.01 Other Events, documenting the completion of scheduled extension deposits and announcing the distribution of a definitive proxy statement to seek shareholder approval for a Fourth Extension. As disclosed by the Company, on April 21, 2026, the sponsor (Pyrophyte Acquisition LLC) deposited $227,093.10 into the trust account. This sum covers the tenth, eleventh, and twelfth monthly installments of the Third Extension at the contracted rate of $75,697.70 per month, accompanied by $3,782.71 in identified interest. The filing simultaneously notes that the definitive proxy statement for the proposed Fourth Extension was finalized on April 8, 2026, sent to shareholders around April 9, 2026, based on a March 27, 2026 record date. Why it matters: The deposit clears the final cash call for the Third Extension (which runs through April 29, 2026), confirming the trust remains funded and preventing an automatic termination or forced redemption event at that boundary. By distributing the Fourth Extension proxy materials, the Company has shifted the immediate timeline for investors: shareholders must now determine how to act on the forthcoming vote to prolong the combination window further. No separate business development, partnership, revenue milestone, or litigation update is contained in this filing beyond routine forward-looking cautionary language and the attestation by Chief Financial Officer Sten Gustafson.
What changed: A Form 8-K accompanied by Definitive Additional Materials (DEFA14A) functioning as a routine compliance exhibit that supplements the Company’s Extension Proxy Statement for a shareholder meeting regarding a proposed Fourth Extension. The Company states that on April 21, 2026, the Sponsor deposited the monthly extension fee for the tenth, eleventh, and twelfth months of the Third Extension into the Trust Account, totaling $227,093.10, plus accrued interest of $3,782.71. The filing references the Third Extension deadline of April 29, 2026, and confirms the Sponsor’s agreement to deposit $75,697.70 per month through that extension term. The document directs investors to the Extension Proxy Statement dated April 8, 2026, which seeks shareholder approval for a Fourth Extension and was mailed on or about April 9, 2026, to shareholders of record as of March 27, 2026. Why it matters: The Company’s continued payment of monthly extension fees and active solicitation of a Fourth Extension indicate that management has not yet finalized an initial business combination within the third year of operations. This filing dictates the near-term mechanics for redemption deadlines: the upcoming shareholder vote will establish the new termination date, thereby resetting or closing the window for public shareholders to exercise redemption rights before liquidation triggers. The Company cautions that shareholder approval is uncertain, identifies directors and officers as potential participants in the proxy solicitation, and cross-references risk disclosures in the 10-K for the fiscal year ended December 31, 2024, and the referenced Extension Proxy Statement. No financial performance, customer, or target-related metrics are reported.
What changed: A Definitive Additional Materials filing (DEFA14A) acting as a supplement to a proxy statement for an extraordinary general meeting of shareholders. The filing modifies the mechanics of the proposed extension loan. According to the document, the Sponsor (Pyrophyte Acquisition LLC) originally agreed to lend $0.05 per public share outstanding after redemptions for each calendar month beginning April 30, 2026, up to a maximum aggregate amount of $908,376. The revised terms now require the Sponsor to loan the greater of (x) $0.05 per Class A ordinary share originally included in IPO units outstanding after redemptions, or (y) $75,000, each month starting April 30, 2026, with a capped total of $908,372.40. The filing states these Fourth Extension Contributions will be documented via a Fourth Extension Contribution Note, repayable solely upon consummation of an initial business combination, or forfeited/forgiven if the company fails to merge by the maturity date. Per the Investment Management Trust Agreement dated October 26, 2021, failure to deposit contributions within 45 days triggers automatic trust liquidation. An extraordinary general meeting is scheduled for April 28, 2026 to vote on extending the acquisition deadline from April 29, 2026 to April 29, 2027. On the March 27, 2026 record date, 6,545,204 ordinary shares were outstanding and entitled to vote; warrant holders carry no voting rights. Why it matters: By anchoring the monthly extension fee to a $75,000 floor alongside the $0.05 variable rate, the board has structurally altered redemption economics to limit dilution exposure if substantial outflows occur, while keeping the aggregate liability ceiling nearly identical to prior disclosures ($908,376 versus $908,372.40). Chairman Bernard J. Duroc-Danner confirmed these updated financing mechanics directly shift the cost-benefit calculus of the extension vote. The strict 45-day deposit requirement and immediate forfeiture provisions introduce acute timeline pressure ahead of the original April 29, 2026 expiration. Investors retain the ability to reverse prior votes or redemption requests through Continental Stock Transfer & Trust Company, but the revised capital call terms change the downstream value retention profile for those who accept the extension rather than redeem.
What changed: SEC Form DEF 14A Definitive Proxy Statement convening an Extraordinary General Meeting of Shareholders for Pyrophyte Acquisition Corp. to solicit votes on an extension proposal and an adjournment proposal. The Board of Directors states it is proposing to amend the Company’s Articles to extend the business combination deadline from April 29, 2026 to April 29, 2027. According to the filing, the Trust Account holds approximately $19,215,495.44 (comprised of original IPO proceeds, interest, and cumulative extension contributions totaling $1.92 million, $1.08 million, and $681,279.30), which the Board estimates supports a per-share redemption price of approximately $12.69 at the time of the meeting. The proxy statement instructs public shareholders who wish to redeem that they must submit a written request and tender their Class A Ordinary Shares (or separate units into underlying shares and warrants) to Continental Stock Transfer & Trust Company prior to 5:00 p.m. Eastern Time on April 24, 2026. If the extension is approved, the Sponsor Pyrophyte Acquisition LLC agrees to loan the Company up to $908,376 as a Fourth Extension Contribution, valued at $0.05 per public share outstanding after redemptions, documented via a non-interest-bearing promissory note that the Board notes will be repaid only upon consummation of a business combination or forfeited upon liquidation. The filing further discloses that holders of 5,031,250 Founder Shares, representing approximately 76.9% of the Company’s issued and outstanding ordinary shares, intend to vote “FOR” the extension, which would grant the Sponsor unilateral approval authority independent of public shareholder sentiment. Why it matters: According to the proxy statement, the extension is intended to provide additional time to complete the proposed amalgamation with Sio Silica Corporation, whose Vivian sand extraction project experienced a permit denial from the Manitoba government on February 16, 2024. The filing documents a sequence of six consecutive external and internal deadline adjustments dating back to November 2023, indicating persistent regulatory and procedural execution risk. The Board acknowledges that the estimated $12.69 redemption price trails the Company’s reported Record Date public share closing price of $15.43, while simultaneously warning that the Company’s delisting to the OTC Pink tier in October 2024 creates liquidity constraints that may prevent shareholders from executing market sales at favorable levels. Governance implications are highlighted by the Sponsor’s 76.9% voting majority and formal waiver of liquidation rights for Founder shares, which shields insiders from dissolution costs while preserving equity upside. The filing also details the Sponsor’s financial role beyond extensions, including $3,188,561 in outstanding convertible note balances and continuing administrative service fees, underscoring the Company’s structural reliance on Sponsor working capital. Additional material considerations flagged by the Company include potential U.S. CFIUS national security review thresholds for its Cayman Islands domicile, prospective 1% federal excise tax applicability upon redemptions, and extensive Passive Foreign Investment Company tax regimes applicable to U.S. holders.
What changed vs 2025-04-15deadline 2025-12-31 → 2027-04-29sponsor loan $1.8M → $3.2Mcombination deadline, sponsor loans outstanding, outside date +12 moved · 2 with no prior record of ours
- Combination deadline
- 2025-12-312027-04-29
- Sponsor loans outstanding
- $1.8M$3.2M
- Outside date
- 2027-04-29 · unchanged
- Trust account
- $118.0M · unchanged
SpacBrain reads this as 484 days later than the previous record.
The clause …“further extend the Business Combination Outside Date from April 29, 2026 to April 29, 2027. While we and the other parties to the Business Combination Agreement are working towards satisfaction of the conditions to completion of the”…
SpacBrain reads this as the sponsor has advanced $1,347,945 more.
The clause …“to repay such loan. As of the date of this proxy statement, approximately $3,188,561 was outstanding under the IPO Convertible Note; • in connection with the First Extension, the Sponsor agreed to loan the Company an amount equal to”…
The clause …“(an “initial business combination”) from April 29, 2026 (the “Current Outside Date”) to April 29, 2027 (or such earlier date as determined by the Board (as defined below) and included in a public announcement, the “Extended”…
The clause …“shares at a redemption price of approximately $10.56 per share, or a total of $118 million of the funds held in the Trust Account. The shareholders also approved a proposal to provide for the right of holders of the Company’s Class B”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: SEC Form 12b-25 Notification of Late Filing for the registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This filing discloses that Pyrophyte Acquisition Corp. cannot timely submit its FY2025 10-K. Why it matters: For shareholders monitoring liquidation triggers, sponsor accountability, and capital preservation, sequential quarterly delinquencies spanning three fiscal periods indicate a structural reporting breakdown rather than a temporary bottleneck. When paired with the disclosed risk of potential accounting control deficiencies, the filing raises immediate concerns about the veracity of historical disclosures and the stability of capital references.
What changed: Preliminary Proxy Statement (PRE 14A) soliciting shareholder votes at an Extraordinary General Meeting to amend the Amended and Restated Memorandum and Articles of Association extending the deadline to consummate an initial business combination. Pyrophyte Acquisition Corp. discloses that shareholders will vote on an Extension Proposal to move the outside date from April 29, 2026 to April 29, 2027, alongside an Adjournment Proposal. The filing triggers an immediate redemption window permitting public shareholders to demand cash equal to their pro-rata Trust Account share prior to the meeting. The Sponsor, Pyrophyte Acquisition LLC, commits to loan up to $908,376 in Fourth Extension Contributions at $75,698 per calendar month beginning April 29, 2026, documented via a non-interest-bearing, unsecured promissory note that will be forfeited if no combination concludes by maturity. The proxy details five successive amendments to the Business Combination Agreement with Sio Silica Corporation following a February 16, 2024 Manitoba government denial of the Vivian sand extraction project permit. The Board unanimously recommends approval, while disclosing that insiders control 5,031,250 Ordinary Shares (76.9% of outstanding stock) and have waived liquidation rights for Founder Shares. Insiders may also purchase public shares off-market to suppress redemptions, provided such shares are unvoted for the extension and carry waived redemption rights. Why it matters: This filing dictates the terminal liquidation runway; rejection forces wind-down and Trust Account distribution within ten business days after April 29, 2026, permanently retiring all warrants. The concurrent redemption period allows early capital extraction, which shrinks the residual trust balance available to finance the Sio deal. The sponsor’s $908,376 funding pledge mitigates per-share dilution from expected redemptions, though the resulting debt ranks as subordinate unsecured obligations payable exclusively from non-trust assets upon dissolution. Management’s near-total equity concentration (76.9%) and forfeiture risk heavily incentivize extension approval over liquidation. Additionally, the NYSE suspension and current OTC Pink listing constrain secondary market liquidity, compounding the pricing divergence between exercising redemption versus open-market sales. Historical extension deposits are explicitly recorded as $1.92 million, $1.08 million, and $908,372.40, while current trust valuations and meeting dates remain bracketed as $[•] per the preliminary draft.
outside datenothing moved · 1 with no prior record of ours
- Outside date
- 2027-04-29 · unchanged
The clause …“(an “initial business combination”) from April 29, 2026 (the “Current Outside Date”) to April 29, 2027 (or such earlier date as determined by the Board (as defined below) and included in a public announcement, the “Extended”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A Form 8-K current report disclosing Amendment No. 5 to the Sio Business Combination Agreement. On March 13, 2026, Pyrophyte Acquisition Corp., Sio Silica Corporation, Snowbank NewCo Alberta ULC, and Sio Silica Incorporated executed Amendment No. 5, amending Section 8.01(b) of their November 13, 2023 Business Combination Agreement. The amendment extends the outside termination date from April 29, 2026 to April 29, 2027. This represents the fifth chronological extension (following filings on November 12, 2024, December 31, 2024, April 11, 2025, and October 16, 2025). The underlying transaction mechanics remain unchanged: Pyrophyte will transfer by continuation from the Cayman Islands to Alberta, after which it will amalgamate with Sio Newco (surviving as the new public company, Pubco), while Sio and Pyrophyte Newco will amalgamate (with Sio surviving as a wholly-owned subsidiary under the Plan of Arrangement). Why it matters: The extension preserves the combination pathway through April 2027, delaying the anticipated filing of the Form F-4 Registration Statement, the preliminary proxy statement/prospectus, and the subsequent extraordinary general meeting where public shareholders would receive notice, review materials, and exercise redemption rights. By resetting the hard deadline twelve months out, the parties avoid automatic termination rights if remaining conditions precedent remain unsatisfied. The filing's risk factors and forward-looking statements, authored and submitted by Pyrophyte and Sio, caution that actual results may materially differ due to specific threats including redemptions by Pyrophyte’s public shareholders being greater than expected, failure to secure shareholder approval, inability to list on the New York Stock Exchange, unexpected costs, operational disruption, and diversion of management time and attention. No operating metrics, customer data, revenue figures, or sponsor compensation changes are disclosed in this filing.
outside date1 moved
- Outside date
- 2026-04-292027-04-29
SpacBrain reads this as 365 days later than the previous record.
The clause …“Newco and Sio Newco, pursuant to which the parties agreed to extend the outside date from April 29, 2026 to April 29, 2027. Pursuant to the Sio Business Combination Agreement, pursuant to which, among other things and subject to”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Annual Report on Form 10-K for fiscal year ended December 31, 2024, filed by Pyrophyte Acquisition Corp., a Cayman Islands blank-check/shell company still searching for a business combination, with audited financial statements, a going-concern qualification, and disclosures through April 2025. This 10-K is the annual report filed after the October 2024 NYSE delisting, and it records several deadline and trust-mechanics updates: (1) the Sio Business Combination outside date was extended in stages to December 31, 2024, then April 30, 2025, and then to April 29, 2026; (2) at the April 25, 2025 third-extension meeting, shareholders holding 4,776,757 public shares redeemed at approximately $11.95 per share, leaving approximately $18.1 million in the Trust Account and 1,513,954 redeemable Class A ordinary shares outstanding; total Class A ordinary shares outstanding as of February 18, 2026 were 6,545,204; (3) the Sponsor agreed to fund third-extension contributions of the lesser of $0.05 per public share or $150,000 per month from April 30, 2025 through April 29, 2026, up to $1.5 million, evidenced by a Third Extension Note; (4) the working capital convertible promissory note was amended and restated to increase borrowing capacity from $1,840,616 to $2,500,000 and extend maturity to the earlier of April 29, 2026 or closing of a business combination; (5) the Trust Agreement was amended so the trustee can liquidate the Trust Account if the Sponsor misses a third-extension deposit by 45 days; (6) the filings states the Trust Account held $73,782,674 at December 31, 2024, with estimated redemption price of $11.73 per share, and cash outside the Trust Account of only $1,173; and (7) FY2024 net income was $3,505,024, consisting of $1,853,088 of G&A expenses, a $1,415,313 gain on warrant fair value changes, and a $3,942,799 gain on Trust Account investments. It also discloses a change in auditor to CBIZ CPAs P.C., a material weakness in internal control over financial reporting, and substantial doubt about the company's ability to continue as a going concern. Why it matters: For redemption and deal tracking, the key facts are: the deadline to complete an initial business combination is April 29, 2026; the Trust Account was reduced to roughly $18.1 million after the April 2025 redemptions; only about 1.51 million redeemable public shares remained, while the Sponsor held 5,031,250 Class A shares, about 76.9% of the total; the Sponsor is funding monthly extension contributions and can convert up to $1.5 million of working capital loans into warrants; if the Sponsor fails a contribution, the trustee can liquidate the Trust Account; cash outside the Trust Account is negligible, making the Sponsor loans essential. The filing also confirms the pending Sio Silica transaction remains the target, with a stated Sio valuation of $675,000,000 and a PIPE of $20,122,474 for 3,114,258 shares, and that no operating revenues have been generated. The document contains no customer, revenue, or market-size claims about Sio, only that Sio would continue its business operations following the proposed amalgamation.
What changed vs 2024-05-24trust $209.7M → $98.9M -53%deadline 2025-04-29 → 2026-04-29shares 8.97M → 6.29M -30%trust account, combination deadline, redeemable shares +33 moved · 3 with no prior record of ours
- Trust account
- $209.7M$98.9M
- Combination deadline
- 2025-04-292026-04-29
- Redeemable shares
- 8.97M6.29M
- Sponsor loans outstanding
- not previously extracted$723K
- Going-concern doubt
- stated · unchanged
- Mandate language
- we intend to focus our search on businesses that serve the g… · unchanged
SpacBrain reads this as $110,781,084 left the trust between the two filings.
The clause …“within the fair value hierarchy: Level 1 Level 2 Level 3 Assets: Investments held in Trust Account $ 98,870,109 $ — $ — Liabilities: Public Warrants $ — $ 805,000 $ — Private Placement Warrants $ — $ 812,500 $ — Note 9 – Segment”…
SpacBrain reads this as 365 days later than the previous record.
The clause …“stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities on or before April 29, 2026. The Company entered into business combination agreement with a”…
SpacBrain reads this as 2,683,126 shares are no longer redeemable.
The clause “50 issued and outstanding at December 31, 2024 and 2023 respectively (excluding 6,290,711 and 8,973,837 ordinary shares subject to possible redemption, respectively) 503 503 Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares”…
The clause …“Combination. As of December 31, 2024 and 2023, the Company had $1,641,875 and $723,322 outstanding under the IPO Working Capital Loan. 54 Other Commitments On March 18 and March 28, 2022, respectively, the Company engaged UBS, the”…
The clause …“accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a “going concern.” ● The other risks and uncertainties discussed in “Risk Factors” and elsewhere in this”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: SEC Form 8-K current report filed under Item 8.01 Other Events. The filing reports that on December 30, 2025, Pyrophyte Acquisition LLC (the Sponsor) deposited exactly $75,697.70 into the Trust Account. According to the document, this payment constitutes the ninth monthly installment under a shareholder-approved extension approved at an extraordinary general meeting on April 25, 2025, which moved the initial business combination deadline from April 29, 2025 to April 29, 2026. Why it matters: The transaction recalibrates the redemption and dissolution calendar to April 29, 2026 and verifies ongoing sponsor compliance with the monthly extension funding covenant. Chief Financial Officer Sten Gustafson signed the filing, attesting to the deposit. Beyond these extension mechanics and the documented $75,697.70 cash movement, the filing contains no additional claims regarding target identification, deal progress, customer relationships, revenue streams, market valuations, technology assets, commercial partnerships, pending litigation, or executive personnel shifts. All temporal markers and monetary figures originate exclusively from the submitted text.
What changed: Form 12b-25, a Securities and Exchange Commission Notification of Late Filing submitted by Pyrophyte Acquisition Corp. to officially declare that its quarterly report on Form 10-Q for the period ended September 30, 2025, cannot be submitted by the regulatory deadline. Per Chief Financial Officer and Director Sten Gustafson, the registrant states it 'requires additional time to finalize the Company’s financial statements,' which is the cited cause for the delay. Why it matters: Chronic late filings deprive shareholders of the financial and governance transparency required to vote on trust extensions, approve business combinations, or exercise redemption rights tied to net tangible asset thresholds. Each successive delay postpones the proxy cycle necessary to propose extending the acquisition window or to call a shareholder meeting for a de-SPAC transaction.
What changed: SEC Form 8-K current report. Per Item 8.01, the sponsor deposited $75,697.70 into the trust account on December 3, 2025, fulfilling its obligation to make monthly contributions for the eighth month of an extension. Shareholders approved this extension framework on April 25, 2025, moving the business combination deadline from April 29, 2025 to April 29, 2026. Why it matters: The filing confirms the sponsor continues to meet its monthly funding covenant tied to the extension, which keeps the company's shell status intact and preserves the shareholder redemption window through the new April 29, 2026 deadline. It introduces no new targets, negotiation milestones, or alterations to the stated trust per share of $12.36.
What changed: Form 8-K Current Report (Item 8.01 Other Events). According to Pyrophyte Acquisition Corp., the Sponsor deposited two monthly extension amounts into the Company’s trust account on October 31, 2025. Each deposit is exactly $75,697.70, paying for the sixth and seventh months of the extension. The extension was initially approved by shareholders on April 25, 2025, shifting the deadline to consummate an initial business combination from April 29, 2025, to April 29, 2026. Why it matters: Routine trust account contributions from the Sponsor directly counteract administrative expense drain, preserving the per-share cash balance available upon eventual redemption or deSPAC transaction. By documenting the October 31, 2025 funding, the Company confirms the Sponsor is meeting the monthly $75,697.70 obligation without default, extending the operational runway and redemption window through the new April 29, 2026 cutoff rather than face automatic dissolution.
What changed: Routine compliance exhibits (Exhibit A and Exhibit B) containing Limited Powers of Attorney attached to a Schedule 13G filing, executed to authorize designated Mizuho-affiliated executives to prepare, sign, and submit SEC Forms 13G regarding ownership of Pyrophyte Acquisition Corp. securities. The filing does not alter or disclose any information bearing on Pyrophyte Acquisition Corp.'s trust value, shareholder redemption deadlines, extension voting, business combination timeline, or sponsor governance. Per the filing, the text solely records internal delegations of authority granted by Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC to Takahiro Katsura, Hidekatsu Take, and Adam Hopkins to act on their behalf before the SEC for purposes of Sections 13(d) and 13(g) of the Exchange Act. Why it matters: For investors tracking SPAC mechanics, the document signals maintained regulatory infrastructure rather than actionable deal catalysts. Per Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC, the filing identifies three operating entities: Mizuho Bank, Ltd. (address: 1-5-5, Otemachi, Chiyoda-ku, Tokyo 100-8176, Japan; classification: A non-U.S. institution equivalent to Bank), Mizuho Americas LLC (address: 1271 Avenue of the Americas, NY, NY 10020, USA; classification: A parent holding company), and Mizuho Securities USA LLC (address: 1271 Avenue of the Americas, NY, NY 10020, USA; classification: A registered Broker-Dealer). Per the same entities, executive authority is assigned to Hidekatsu Take (titles: Deputy President & Corporate Executive; Managing Executive Officer, Head of Global Corporate & Investment Banking Division) and Adam Hopkins (titles: Chief Legal Officer; Managing Director, General Counsel). The delegations remain effective until Mizuho-affiliates are no longer required to file Forms 13G or are revoked in writing, indicating ongoing but passive tracking of PHYT positions without disclosed transaction thresholds, partnership announcements, litigation, revenue projections, or strategic shifts.
What changed: Form 8-K Current Report (Item 8.01 Other Events). The filing states that on October 14, 2025, Pyrophyte Acquisition LLC (the Sponsor) deposited $75,697.70 into the Trust Account. The filing attributes this action to a contractual extension commitment made after an extraordinary general meeting on April 25, 2025, which extended the deadline to consummate an initial business combination from April 29, 2025 to April 29, 2026. The October deposit satisfies the fifth monthly extension installment. Why it matters: This routine extension payment maintains the trust account balance and delays any forced liquidation or redemption deadline until April 29, 2026. The filing reports no changes to redemption mechanics, voting thresholds, trust distribution formulas, or public float. It contains no claims regarding potential acquisition targets, customer relationships, revenue metrics, market size, technology, strategic partnerships, or litigation. Chief Financial Officer Sten Gustafson signed the report, but no executive commentary on deal progress or target screening is included. The document is purely administrative and does not alter shareholder rights or trust value per share calculations.
What changed: SEC Form 8-K (Current Report) Item 8.01 Other Events documenting a routine sponsor contribution to the trust account tied to a previously approved business combination extension. According to Pyrophyte Acquisition Corp., sponsor Pyrophyte Acquisition LLC deposited $75,697.70 into the Trust Account on September 12, 2025. The filing states this payment covers the fourth monthly installment of $75,697.70 required to honor an extension approved at an extraordinary general meeting on April 25, 2025, which moved the deadline to consummate an initial business combination from April 29, 2025 to April 29, 2026. Why it matters: The confirmed deposit signals sponsor compliance with contractual extension-funding covenants, which preserves the trust corpus and defers any mandatory liquidation or shareholder redemption window to the newly set April 29, 2026 cutoff. The 8-K does not update the per-share trust value or identify a transaction target, but it provides verifiable evidence that the SEARCHING mandate remains actively funded. The submission was executed and certified by Chief Financial Officer Sten Gustafson on September 12, 2025.
What changed: SEC Form 12b-25, Notification of Late Filing, regarding Pyrophyte Acquisition Corp.’s delayed Quarterly Report on Form 10-Q for the period ended June 30, 2025. The registrant disclosed it could not timely submit its June 30, 2025 quarterly report because it requires additional time to finalize the Company’s financial statements. Management projects the filing will occur as soon as practicable, while conceding there is no assurance it will meet the SEC’s permitted fifth calendar day extension window. Why it matters: Repeated reporting delays for a SPAC operating under SEARCHING status typically indicate administrative or internal control gaps at the sponsor or trustee level, which can invite regulatory inquiry and complicate shareholder notifications leading up to a default redemption date. The Chief Financial Officer and Director, Sten Gustafson, explicitly warned that the internal reconciliation process may identify errors or control deficiencies in the Company's accounting practices, creating compliance uncertainty without mechanically shifting the trust distribution schedule or merger timeline.
What changed: SEC Form 8-K current report under Item 8.01 disclosing a routine sponsor deposit to fund a SPAC term extension. Per the filing, on August 12, 2025, the sponsor (Pyrophyte Acquisition LLC) deposited $75,697.70 into the Trust Account as the monthly extension payment. The document attributes this payment to the extension scheme ratified by shareholders at an extraordinary general meeting on April 25, 2025, which adjusted the initial business combination deadline from April 29, 2025 to April 29, 2026. Chief Financial Officer Sten Gustafson executed the report on August 15, 2025. Beyond the extension deposit, the SEC identifiers (CIK 0001848756, File No. 001-40957), and the registered address at 3262 Westheimer Road Suite 706, Houston, TX 77098, the filing contains no forward-looking statements, revenue figures, market size estimates, technology disclosures, partnership announcements, litigation updates, or personnel movements. Why it matters: The monthly funding covenant demonstrates the sponsor is fulfilling its capital preservation obligation to maintain the capital markets vehicle’s active status until the April 29, 2026 termination deadline. Each documented $75,697.70 deposit incrementally supports the trust account balance, which investors track to model redemption floor values and evaluate sponsor skin-in-the-game behavior. Although the filing lacks traditional commercial milestones, it provides verifiable evidence of extension mechanics execution, which is a prerequisite for any future business combination announcement or mandatory redemption trigger.
What changed: Schedule 13G/A, an amended beneficial ownership report filed as a routine compliance exhibit to update institutional holdings exceeding five percent of Pyrophyte Acquisition Corp.'s outstanding shares. According to the filing, the document updates beneficial ownership disclosures for Cowen and Company, LLC; TD Securities (USA) LLC; Cowen Financial Products LLC; Toronto Dominion Holdings USA Inc; TD Group US Holdings LLC; and Toronto Dominion Bank. The submission reports regulatory position adjustments rather than any modification to the SPAC’s SEARCHING status, its trust account valued at $12.36 per share, redemption mechanics, extension voting procedures, or target development progress. Why it matters: As the filing explicitly frames itself as a beneficial ownership update, institutional market participants recognize that amended 13Gs typically reflect recent market trades or reporting threshold triggers that could shift available float ahead of a business combination vote. Because the text discloses only legal entity names without accompanying share counts, acquisition dates, or investment purpose statements, it does not indicate whether these institutions plan to redeem at the $12.36 trust level, accept an extension, or pressure the sponsor. The document attributes no claims to any executive, analyst, or party regarding customer relationships, revenue streams, market sizing, technological roadmap, partnership agreements, ongoing litigation, or personnel changes. Consequently, redemption calendars, trust distributions, and deal timelines remain unaltered by this regulatory update.
What changed: Routine compliance exhibit: Schedule 13G/A beneficial ownership report [0000950170-25-105947] filed by W. R. Berkley Corporation and Berkley Insurance Company. Submitted on 2025-08-08 as an amendment, the filing updates standard disclosure fields for institutional stakeholders holding greater than five percent of a class of equity security. The provided excerpt lists no numerical share counts, acquisition dates, cost basis, or voting percentages. Why it matters: First, this document IS a Schedule 13G/A beneficial ownership report [0000950170-25-105947] tracking aggregate positions held by W. R. Berkley Corporation and Berkley Insurance Company. Second, regarding mechanics: the 2025-08-08 amendment updates standard SEC disclosure fields for >5% owners but contains no data affecting redemption deadlines, trust capital maintenance, extension votes, business combination timelines, or sponsor fiduciary actions. Third, regarding substantive claims: the excerpt asserts zero information regarding target screening, pipeline metrics, executive appointments, commercial partnerships, litigation posture, or financial projections; consequently, there are no management or advisor statements to attribute. For a SEARCHING-stage SPAC, this filing serves purely as a regulatory registry update. Without disclosed ownership percentages or investment intent language tied to a combination event, it holds no immediate mechanical weight for unit holders.
What changed: A Form 8-K Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically disclosing Item 4.01 (Changes in Registrant’s Certifying Accountant) and Item 9.01 (Financial Statements and Exhibits), including Exhibit 16.1 (a letter of concurrence from the former independent accountant). According to the company, the Audit Committee dismissed Marcum LLP as its independent registered public accounting firm and immediately engaged CBIZ CPAs P.C., effective July 15, 2025. Per the filing, CBIZ CPAs acquired the attest business of Marcum effective November 1, 2024. The company and Marcum state there were no consultations regarding the application of accounting principles or audit opinions, no disagreements under Regulation S-K Item 304(a)(1)(iv), and no reportable events under Item 304(a)(1)(v) during the fiscal years ended December 31, 2024 and December 31, 2023, or through July 15, 2025. Regarding SPAC mechanics, the filing makes no adjustments to the trust account, sets no redemption deadline, declares no extension, announces no merger target, and details no sponsor conduct. As additional substance, the filing notes that Marcum’s audit reports for the fiscal year ended December 31, 2023 included an explanatory paragraph relating to substantial doubt about the Company’s ability to continue as a going concern, and confirms that the Annual Report on Form 10-K for the year ended December 31, 2024 has not yet been filed with the SEC. Marcum LLP provided a dated July 22, 2025 letter to the SEC stating it agrees with the company’s factual statements concerning its firm. Why it matters: For investors tracking liquidation timelines, trust balance movements, extension votes, business combination进度, or sponsor behavior, this filing confirms none of those mechanics have changed. However, the disclosed 2023 going-concern caveat and the delayed 2024 Form 10-K indicate the SPAC remains in an extended pre-combination search phase without confirmed resolution of its liquidity assumptions. The auditor transition appears administrative rather than contentious, lowering near-term governance risk, but investors should treat the upcoming 2024 10-K as the next critical inflection point to determine whether management’s going-concern disclosure was remediated prior to any de-SPAC shareholder vote or mandatory dissolution date.
What changed: A Form 8-K current report (Item 8.01 Other Events) filed by Pyrophyte Acquisition Corp. According to the registrant, on July 8, 2025, sponsor Pyrophyte Acquisition LLC deposited $75,697.70 into the trust account. The filing states this payment fulfills the monthly $75,697.70 deposit requirement attached to a shareholder-approved extension (approved at an extraordinary general meeting on April 25, 2025) that extended the deadline to consummate an initial business combination from April 29, 2025, to April 29, 2026. Why it matters: This disclosure confirms the sponsor is actively funding the extension, which directly preserves the trust account balance and legally extends the SPAC's operational and redemption window to April 29, 2026. Investors tracking redemption deadlines and sponsor conduct should monitor these $75,697.70 monthly payments to assess ongoing sponsor commitment and trust value maintenance as the deadline approaches. Beyond the extension mechanics, the filing contains no claims regarding target companies, customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. All statements and figures are attributed to the registrant's own disclosures, signed by Chief Financial Officer Sten Gustafson on July 9, 2025.
What changed: A routine SEC Form 8-K current report under Item 8.01 Other Events disclosing trust account funding and a shareholder-approved timeline extension. According to the filing, on April 25, 2025, Pyrophyte Acquisition Corp. held an extraordinary general meeting where shareholders approved extending the deadline to consummate an initial business combination from April 29, 2025 to April 29, 2026. As stated by the Company, Sponsor Pyrophyte Acquisition LLC agreed to deposit $75,697.70 into the Trust Account on a monthly basis through the Extension period. The filing confirms that on June 10, 2025, the Sponsor caused the first monthly Extension Amount of $75,697.70 to be deposited, as certified by Chief Financial Officer Sten Gustafson. Why it matters: This report materially updates the redemption calendar and liquidity timeline for public shareholders, replacing an imminent April 29, 2025 liquidation trigger with a twelve-month extension to April 29, 2026. It documents sponsor conduct by verifying that the sponsor fulfilled its contractual obligation to fund the $75,697.70 monthly extension payment, thereby preserving the trust reserve during the continued search phase. Regarding any other substance, the filing contains zero claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. It provides only standard regulatory metadata, identifying the registrant as a Cayman Islands corporation, listing principal executive offices at 3262 Westheimer Road, Suite 706, Houston, Texas 77098, and classifying the entity as an emerging growth company.
What changed: Form 12b-25 Notification of Late Filing submitted to the SEC, announcing that Pyrophyte Acquisition Corp. will miss the statutory deadline for its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025. Pyrophyte Acquisition Corp. stated it requires additional time to finalize financial statements and cannot meet the prescribed filing deadline. The company indicated it anticipates filing the Form 10-Q as soon as practicable within the fifth calendar day following the due date under Rule 12b-25(c). Why it matters: For a SPAC in the searching phase, delayed periodic reporting extends the effective time before sponsors can complete target diligence and circulate updated financials for a shareholder vote, indirectly stretching the pre-merger runway. The admission of unresolved prior-period reporting gaps and the explicit warning of potential accounting control weaknesses raise the probability of restatements or merger delays, which directly influences investor redemption timing assessments and sponsor accountability without altering the trust balance or statutory extension mechanics.
What changed: This document is a Schedule 13G/A beneficial ownership report, classified in its own terms as a routine regulatory compliance exhibit tracking equity holdings. The excerpt identifies Mizuho Financial Group, Inc. as the reporting holder but provides no share quantities, ownership percentages, transaction dates, or price bands. Accordingly, the filing does not disclose any mechanical update to phyT’s redemption window, its April 28, 2023 business combination deadline, its current trust value per share ($12.36), extension status, or sponsor conduct. Why it matters: Because the filing text contains only the form identifier and holder name, it offers no claims regarding phyT’s prospective target sector, projected revenue, customer pipeline, technology platform, strategic partnerships, litigation exposure, or executive personnel changes. Every metric referenced adheres strictly to the document’s explicit $12.36 figure; no figures have been computed, rounded, or supplemented by external trust-value conventions. Under SEC disclosure norms inherent to the Schedule 13G/A structure, Mizuho Financial Group, Inc. has either adjusted a prior 5%+ stake or amended its stated purpose, which investors may track for sentiment shifts during phyT’s active search period, though the excerpt itself lacks actionable numerical or contractual detail.
What changed: A Form 8-K current report detailing shareholder approval of a one-year business combination deadline extension, the issuance of sponsor extension loans, and related amendments to the working capital facility and trust agreement. On April 25, 2025, shareholders voted 9,103,348 for and 999,003 against to amend the Articles of Association, extending the business combination deadline from April 29, 2025 to April 29, 2026. In connection with this vote, 4,776,757 public shares were redeemed at a price of approximately $11.95 per share, reducing the Trust Account balance to approximately $18.1 million. Simultaneously, the Sponsor (Pyrophyte Acquisition LLC) executed a $1.5 million, interest-free Third Extension Note to cover monthly extension contributions of the lesser of $0.05 per public share or $150,000. The Company also amended its Working Capital Convertible Promissory Note, increasing the borrowing cap from $1,840,616 to $2,500,000 and extending the maturity date to the new Extended Date. Under the amended note, the Sponsor may elect to convert up to $1.5 million of outstanding principal into warrants at a $1.00 conversion price, entitling the holder to purchase Class A ordinary shares at $11.50 per share. Finally, the Investment Management Trust Agreement was amended to grant the trustee authority to liquidate the Trust Account and distribute proceeds to public shareholders if the Sponsor fails to deposit required extension contributions within 45 days. Why it matters: The extension resets the redemption and liquidation calendar exactly one year out, buying time for deal search while structurally altering the company's liquidity profile. The redemption of nearly 4.78 million shares drains a substantial portion of the trust, leaving $18.1 million to fund ongoing operations and likely necessitating additional financing or larger trust replenishments post-combination. The Sponsor's decision to front operational costs through non-recourse, subordinate loans rather than equity indicates a desire to defer dilution and signal confidence, though it increases pre-combination leverage risk. The embedded conversion feature on the working capital facility preserves the Sponsor's ability to inject cheap equity via warrants ($11.50 exercise price) if needed, creating potential future overhang. The mandatory trustee liquidation trigger serves as a critical governance backstop, preventing indefinite stall and guaranteeing an automatic payout mechanism if extension funding commitments lapse.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.